Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Innovative Solutions Opening (ISO)
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
About this opportunity
February 23, 2026 ADVOCATE ISO, ARPA-H-SOL-26-142, Amendment 02: The purpose of ARPA-H-SOL-26-142, Amendment 02 is to revise the following sections as shown in the highlighted text: Table of Contents TA1: CVD Agent � Reliable Agentic Care Management under Section 1.2.1 Technical Areas (TA) Phase 2 (15 months) � Scalability Studies under Section 1.2.2 Program Structure & Timeline Section 3. Submission Information Section 4.1 Solution Summary Review Process Section 4.2 Full Proposal Evaluation Criteria Section 4.2.1 Criteria 1: Overall Scientific and Technical Merit Section 4.4 Handling of Sensitive Information See attached ADVOCATE ISO, ARPA-H-SOL-26-142, Amendment 02. __________________________ February 5, 2026 ADVOCATE ISO, ARPA-H-SOL-26-142, Amendment 01: The purpose of ARPA-H-SOL-26-142...